Veru Inc ROCE
Was ist das ROCE von Veru Inc?
ROCE von Veru Inc ist -71.45%
Was ist die Definition von ROCE?
Die Kapitalerträge (ROCE) entsprechen einer Finanzkennzahl, die die Rentabilität eines Unternehmens und die Effizienz, mit der sein Kapital verwendet wird, misst.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Veru Inc
Was macht Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Unternehmen mit roce ähnlich Veru Inc
- Metacrine hat ROCE von -71.78%
- Ashmore Global Opportunities hat ROCE von -71.75%
- Parabolic Drugs hat ROCE von -71.59%
- Ridgestone Mining hat ROCE von -71.58%
- Green Panda Capital hat ROCE von -71.52%
- Frontier Lithium hat ROCE von -71.52%
- Veru Inc hat ROCE von -71.45%
- Predictive Technology hat ROCE von -71.44%
- Cambium Networks Corp hat ROCE von -71.36%
- Velodyne Lidar hat ROCE von -71.32%
- Axovant Gene Therapies hat ROCE von -71.27%
- Forbidden Foods hat ROCE von -71.11%
- Atlas Cycles (Haryana) hat ROCE von -71.08%